pharmacokinetic analysis post-processing platform with dedicated software tissue-4d (Siemens Healthineers)
90
Structured Review
Siemens Healthineers
pharmacokinetic analysis post-processing platform with dedicated software tissue-4d
Pharmacokinetic Analysis Post Processing Platform With Dedicated Software Tissue 4d, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+processing+platform/tissue4d/pm39923105-77-6-9
Average 90 stars, based on 1 article reviews
Pharmacokinetic Analysis Post Processing Platform With Dedicated Software Tissue 4d, supplied by Siemens Healthineers, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/post+processing+platform/tissue4d/pm39923105-77-6-9
Average 90 stars, based on 1 article reviews
pharmacokinetic analysis post-processing platform with dedicated software tissue-4d - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Differential diagnosis of thyroid nodules by DCE-MRI based on compressed sensing volumetric interpolated breath-hold examination: A feasibility study. Article Snippet: Objectives: To explore the potential and performance of quantitative and semi-quantitative parameters derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) based on compressed sensing volumetric interpolated breath-hold (CS-VIBE) examination in the differential diagnosis of thyroid nodules.. Materials and methods: A total of 208 patients with 259 thyroid nodules scheduled for surgery operation were prospectively recruited.. All participants underwent routine and DCE-MRI. Article Title: Golden-angle radial sparse parallel magnetic resonance imaging of rectal perfusion: utility in the diagnosis of poorly differentiated rectal cancer Article Snippet: The manipulation of images was executed through the utilization of a commercially Article Title: Rim enhancement of pancreatic ductal adenocarcinoma: investigating the relationship with DCE-MRI-based radiomics and next-generation sequencing Article Snippet: Pharmacokinetic maps were generated from Software:Article Title: Development and validation of a point-based scoring system for predicting axillary lymph node metastasis and disease outcome in breast cancer using clinicopathological and multiparametric MRI features. Article Snippet: The contrast agent gadopentetate dimeglumine (Bayer Pharmaceuticals Corporation) at a dose of 0.2 ml/kg was given by intravenous injection at a rate of 3.0 ml/s. .. MR image analyses were performed on the Article Title: Preoperative prediction of IDH genotypes and prognosis in adult-type diffuse gliomas: intratumor heterogeneity habitat analysis using dynamic contrast-enhanced MRI and diffusion-weighted imaging. Article Snippet: .. A pharmacokinetic analysis post-processing platform with Article Title: A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score Article Snippet: An intravenous contrast agent (Medtron AG, Saarbruecken, Germany) was then administered at a rate of 1 ml kg − 1 body weight and 2.5 ml s − 1 injection rate. .. Finally, the Article Title: Earlier consolidation and improved knee function of medial open wedge high tibial osteotomy with autologous bone graft. Article Snippet: .. Images of the DCE-MRI were postprocessed by a Generated:Article Title: Development and validation of a point-based scoring system for predicting axillary lymph node metastasis and disease outcome in breast cancer using clinicopathological and multiparametric MRI features. Article Snippet: The contrast agent gadopentetate dimeglumine (Bayer Pharmaceuticals Corporation) at a dose of 0.2 ml/kg was given by intravenous injection at a rate of 3.0 ml/s. .. MR image analyses were performed on the Construct:Article Title: A novel clinically significant prostate cancer prediction system with multiparametric MRI and PSA: P.Z.A. score Article Snippet: An intravenous contrast agent (Medtron AG, Saarbruecken, Germany) was then administered at a rate of 1 ml kg − 1 body weight and 2.5 ml s − 1 injection rate. .. Finally, the |